Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
La Chlogen is an antimicrobial oral care product containing a low-concentration, high-purity hypochlorous acid (HOCl) solution (100 ppm) as its active ingredient. Developed by La Chlogen Biotechnology in Taiwan, it is primarily used as a therapeutic mouthwash to reduce oral bacterial load and manage periodontal diseases. The active ingredient, hypochlorous acid, is a powerful oxidizing agent that mimics the natural antimicrobial substances produced by human white blood cells. It provides broad-spectrum bactericidal activity by non-specifically disrupting bacterial cell membranes and inactivating essential proteins and nucleic acids. La Chlogen is often utilized in conjunction with the La Chlogen periodontal flosser, a dedicated medical device designed to deliver the antimicrobial solution effectively into periodontal pockets and interdental spaces.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on La Chlogen.